Altoida, Inc.

📍 Washington, United States🗓 Founded 2016👥 30 employees💰 Last funded 2022
Hospitals and Health Care🌐 altoida.com
Website LinkedIn
Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.
7
Total investors
4
Early stage
2
Mid stage
1
Late stage
2016
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography6 countries
United States
2
Germany
1
Netherlands
1
Switzerland
1
Jordan
1
Spain
1
Investor activity2016–2022 · investors recorded per year
20164201912020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Altoida, Inc.?
Altoida, Inc. has 7 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage and 1 late-stage investors.
When did Altoida, Inc. last raise funding?
The most recent investment in Altoida, Inc. recorded on gritt.io was in 2022.
When was Altoida, Inc. founded?
Altoida, Inc. was founded in 2016.
What industry is Altoida, Inc. in?
Altoida, Inc. operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Altoida, Inc. based?
Altoida, Inc. is headquartered in Washington, United States.